House Republicans Aim To Eliminate Tax Credits For Orphan Drugs
For more than three decades, pharmaceutical companies have claimed a 50 percent tax credit for the cost of clinical trials of drugs for rare diseases. The credit is now in jeopardy.
Read more on NPR
Health Care
November 4, 2017 at 12:30AM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét